CIK 0001609809 · Non-accelerated filer<br>Smaller reporting company
Seres Therapeutics, Inc.
Sign in to watch- Ticker
- MCRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 274326290
- Phone
- 617 945 9626
- Business address
- 200 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- Seres Therapeutics, Inc., Seres Health, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,230
- in 4 filings, $2K under 10b5-1 plans
Net −$2,230. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-10 | Graves Kurt Director | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2025-04-10 | Berenson Stephen Director | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2025-04-10 | Kender Richard N Director | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2025-04-10 | Ausiello Dennis A Director | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2025-04-10 | Dere Willard H Director | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2025-02-18 | Young Teresa L. See Remarks | Sale 10b5-1 | −3,338 | $0.81 | $3K | 97,536 |
| 2025-02-18 | Henn Matthew R. See Remarks | Sale 10b5-1 | −3,953 | $0.81 | $3K | 84,443 |
| 2025-02-18 | Shaff Eric D. CEO and President | Sale 10b5-1 | −12,726 | $0.81 | $10K | 192,039 |
| 2025-02-18 | DesRosier Thomas Chief Legal Officer and EVP | Sale 10b5-1 | −4,300 | $0.81 | $3K | 142,456 |
| 2025-02-18 | von Moltke Lisa See Remarks | Sale 10b5-1 | −4,416 | $0.81 | $4K | 39,875 |
| 2025-02-15 | Young Teresa L. See Remarks | Option exercise 10b5-1 | +2,657 | 93,061 | ||
| 2025-02-15 | Young Teresa L. See Remarks | Option exercise 10b5-1 | +7,813 | 100,874 | ||
| 2025-02-15 | Young Teresa L. See Remarks | Option exercise · Restricted Stock Units 10b5-1 | −2,657 | 21,250 | ||
| 2025-02-15 | Young Teresa L. See Remarks | Option exercise · Restricted Stock Units 10b5-1 | −7,813 | 23,437 | ||
| 2025-02-15 | Henn Matthew R. See Remarks | Option exercise 10b5-1 | +2,813 | 80,583 | ||
| 2025-02-15 | Henn Matthew R. See Remarks | Option exercise 10b5-1 | +7,813 | 88,396 | ||
| 2025-02-15 | Henn Matthew R. See Remarks | Option exercise · Restricted Stock Units 10b5-1 | −2,813 | 22,500 | ||
| 2025-02-15 | Henn Matthew R. See Remarks | Option exercise · Restricted Stock Units 10b5-1 | −7,813 | 23,437 | ||
| 2025-02-15 | Shaff Eric D. CEO and President | Option exercise 10b5-1 | +7,813 | 178,202 | ||
| 2025-02-15 | Shaff Eric D. CEO and President | Option exercise 10b5-1 | +26,563 | 204,765 |
Page 8 of 13 · 254 trades